UA60149U - Method for correcting cell-mediated immunity in patients with chronic non-calculous cholecystitis in setting of increased fatigability in course of long-term follow-up - Google Patents

Method for correcting cell-mediated immunity in patients with chronic non-calculous cholecystitis in setting of increased fatigability in course of long-term follow-up

Info

Publication number
UA60149U
UA60149U UAU201014313U UAU201014313U UA60149U UA 60149 U UA60149 U UA 60149U UA U201014313 U UAU201014313 U UA U201014313U UA U201014313 U UAU201014313 U UA U201014313U UA 60149 U UA60149 U UA 60149U
Authority
UA
Ukraine
Prior art keywords
patients
course
setting
long
mediated immunity
Prior art date
Application number
UAU201014313U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Александр Николаевич Трофименко
Валерий Митрофанович Фролов
Евгений Дмитриевич Андросов
Original Assignee
Александр Николаевич Трофименко
Валерий Митрофанович Фролов
Евгений Дмитриевич Андросов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Александр Николаевич Трофименко, Валерий Митрофанович Фролов, Евгений Дмитриевич Андросов filed Critical Александр Николаевич Трофименко
Priority to UAU201014313U priority Critical patent/UA60149U/en
Publication of UA60149U publication Critical patent/UA60149U/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A method for correcting the cell-mediated immunity in the patients with chronic non-calculous cholecystitis in the setting of the increased fatigability in the course of long-term follow-up provides for the use of spasmolytics, cholagogues, antibacterial agents, Manax as natural immunoactive drug, and the artichoke extract.
UAU201014313U 2010-11-30 2010-11-30 Method for correcting cell-mediated immunity in patients with chronic non-calculous cholecystitis in setting of increased fatigability in course of long-term follow-up UA60149U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201014313U UA60149U (en) 2010-11-30 2010-11-30 Method for correcting cell-mediated immunity in patients with chronic non-calculous cholecystitis in setting of increased fatigability in course of long-term follow-up

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201014313U UA60149U (en) 2010-11-30 2010-11-30 Method for correcting cell-mediated immunity in patients with chronic non-calculous cholecystitis in setting of increased fatigability in course of long-term follow-up

Publications (1)

Publication Number Publication Date
UA60149U true UA60149U (en) 2011-06-10

Family

ID=50834237

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201014313U UA60149U (en) 2010-11-30 2010-11-30 Method for correcting cell-mediated immunity in patients with chronic non-calculous cholecystitis in setting of increased fatigability in course of long-term follow-up

Country Status (1)

Country Link
UA (1) UA60149U (en)

Similar Documents

Publication Publication Date Title
MX2023000320A (en) Methods of modulating drug plasma levels using erythrohydroxybupropion.
EP3378861A4 (en) Acrylic acid derivative, preparation method and use in medicine thereof
MX367109B (en) Synergistic bacterial compositions and methods of production and use thereof.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
MX2016008448A (en) Var2csa-drug conjugates.
WO2012051344A3 (en) Maintaining multiple defined physiological zones using model predictive control
DK3281607T3 (en) IMPLANTABLE PROTECTION WITH ACELLULAR Tissue Adhesives.
PL3777963T3 (en) Triphasic pulses to reduce undesirable side-effects in cochlear implants
PT2829250T (en) Dental implant, abutment, implant system and implantation set
IL231120A0 (en) Implantable medical devices with increased immune tolerance, and methods for making and implanting
EP3193919A4 (en) Immunogenic/therapeutic glycoconjugate compositions and uses thereof
EP3318879A4 (en) Gpc3-targeted therapeutic agent administered to patient in whom gpc3-targetd therapeutic ag
MX339243B (en) Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof.
EP3644795A4 (en) Improvements in and relating to safety stools
EP3145568A4 (en) Device to reduce discomfort in the upper airway
EP3650448A4 (en) Indole-formamide derivative, preparation method therefor and use thereof in medicine
EP3122376A4 (en) Metabolically-activated drug conjugates to overcome resistance in cancer therapy
EP3124032A4 (en) Asarum total polysaccharides extract having antitussive activity and extraction method and use thereof
MX2021003908A (en) Long-acting polypeptides and methods of producing and administering same.
EP3187147A4 (en) Degradable connector implanted in human body
UA60149U (en) Method for correcting cell-mediated immunity in patients with chronic non-calculous cholecystitis in setting of increased fatigability in course of long-term follow-up
WO2012119049A3 (en) Nutritional compositions comprising prune extract and bioavailable curcumin
WO2011146892A9 (en) Methods and compositions for treating disorders associated with impaired insulin production or secretion
GB201106162D0 (en) Combination vaccine
UA60143U (en) Method for correcting cell-mediated immunity in adolescents with chronic purulent maxillary sinusitis